Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Harnessing Artificial Intelligence for Hypothesis Generation in Childhood Asthma: Insights from NHANES.

Journal of respiratory biology and translational medicine·2026

Same author

eQTM (expression quantitative trait methylation) Atlas: a comprehensive resource of over 11 million DNA methylation-gene expression associations through across 11 tissues and 4 diseases.

bioRxiv : the preprint server for biology·2026

Same author

Depression and asthma across the lifespan.

American journal of respiratory and critical care medicine·2026

Same author

Dietary Patterns and Asthma Endotypes in Puerto Rican Youth.

Chest·2026

Same author

Neural mechanisms of mindfulness-based stress reduction in asthma.

Scientific reports·2026

Same author

Type 2 Diabetes and the Lung - Cause and Consequence.

Current diabetes reports·2026

Search research articles

Related Experiment Videos

Chronic obstructive pulmonary disease in Hispanics.

John M Brehm¹, Juan C Celedón

¹Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA.

American Journal of Respiratory and Critical Care Medicine

|November 22, 2007

Summary

Chronic obstructive pulmonary disease (COPD) prevalence and severity vary significantly among diverse Hispanic populations. Future research should focus on well-defined subgroups to improve understanding and management of COPD in this growing demographic.

Related Experiment Videos

Area of Science:

Pulmonary Medicine
Epidemiology
Public Health

Background:

Hispanics represent a diverse and growing US population with varied health profiles.
Existing data indicate significant variability in chronic obstructive pulmonary disease (COPD) prevalence and morbidity across Hispanic subgroups and nations.
Factors like genetics, environmental exposures (tobacco, biomass smoke), healthcare access, and disease management contribute to this variation.

Purpose of the Study:

To highlight the heterogeneity of COPD within Hispanic populations.
To identify key factors influencing COPD prevalence and morbidity in Hispanics.
To recommend future research directions and public health strategies for managing COPD in this demographic.

Main Methods:

Review of current evidence on COPD in Hispanic populations.
Identification of potential contributing factors to observed variations.
Synthesis of findings to propose future study designs and interventions.

Main Results:

Significant variability in COPD prevalence and morbidity exists among Hispanic subgroups in the US and Latin America.
Genetic background, tobacco and biomass smoke exposure, healthcare access, and management strategies are critical determinants.
Specific high-risk groups and environmental factors (air pollution) require further investigation.

Conclusions:

Future COPD research in Hispanics must utilize large, well-defined subgroups.
Key areas for investigation include diagnostic validation, high-risk group analysis, environmental impact, acculturation effects, and spirometry reference values.
Public health initiatives focusing on smoking cessation, pollution reduction, and improved healthcare access are crucial for reducing the COPD burden in Hispanics.